Multiple Assemblies exist for SMTL entry 8qw7
Crystal Structure of compound 4 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB; X-RAY DIFFRACTION 2.36 Å

SMTL ID 8qw7.1 Ligands (2S,4R)-1-[(2R)-2-[3-[4-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5H-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]butoxy]-1,2-oxazol-5-yl]-3-methyl-butanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide; GUANOSINE-5'-DIPHOSPHATE; MAGNESIUM ION Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; GTPase KRas Oligo-state hetero-1-1-1-1-mer

SMTL ID 8qw7.2 Ligands (2S,4R)-1-[(2R)-2-[3-[4-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5H-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]butoxy]-1,2-oxazol-5-yl]-3-methyl-butanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide; GUANOSINE-5'-DIPHOSPHATE; MAGNESIUM ION Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; GTPase KRas Oligo-state hetero-1-1-1-1-mer